$DRVN Balance Sheet | Understand Stock

$DRVN

$11.61 -$0.08 (0.68%) Close

$DRVN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 27, 2026	Q1 FY2026 As of Mar 28, 2026	Q4 FY2025 As of Dec 27, 2025	Q3 FY2025 As of Sep 27, 2025	Q2 FY2025 As of Jun 28, 2025	Q1 FY2025 As of Mar 29, 2025	Q4 FY2024 As of Dec 28, 2024	Q3 FY2024 As of Sep 28, 2024	Q2 FY2024 As of Jun 29, 2024	Q1 FY2024 As of Mar 30, 2024	Q4 FY2023 As of Dec 30, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jul 1, 2023	Q1 FY2023 As of Apr 1, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 24, 2022	Q2 FY2022 As of Jun 25, 2022	Q1 FY2022 As of Mar 26, 2022	Q4 FY2021 As of Dec 25, 2021	Q3 FY2021 As of Sep 25, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Accounts and notes receivable, net
Inventory
Prepaid and other assets
Income tax receivable
Advertising fund assets, restricted
Assets held for sale
Seller note receivable
Current assets of discontinued operations
Total current assets
Notes receivable, net
Other assets
Property and equipment, net
Operating lease right-of-use assets
Deferred commissions
Intangibles, net
Goodwill
Deferred tax assets
Non-current assets of discontinued operations
Total assets

Liabilities and shareholders' equity
Current liabilities:
Accounts payable
Income taxes payable
Accrued expenses and other liabilities
Income tax payable
Current portion of long-term debt
Tax receivable agreement liability
Income tax receivable liability
Tax receivable agreement payable
Advertising fund liabilities
Current liabilities of discontinued operations
Total current liabilities

Long-term debt
Deferred tax liabilities
Operating lease liabilities
Income tax receivable liability
Tax receivable agreement payable
Deferred revenue
Long-term accrued expenses and other liabilities
Non-current liabilities of discontinued operations
Total liabilities
Preferred Stock $0.01 par value; 100,000,000 shares authorized; none issued or outstanding
Common stock, $0.01 par value, 900,000,000 shares authorized: and 164,979,816 and 164,531,712 shares issued and outstanding; respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders’ equity
Non-controlling interests
Total shareholders' equity
Total liabilities and shareholders' equity
Common stock, shares outstanding (in shares)

Comments